This paper concentrates on the primary theme of Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders in which you have to explain and evaluate its intricate aspects in detail. In addition to this, this paper has been reviewed and purchased by most of the students hence; it has been rated 4.8 points on the scale of 5 points. Besides, the price of this paper starts from £ 40. For more details and full access to the paper, please refer to the site.
Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders
Patient HL comes into the clinic with the following symptoms: nausea, vomiting, and diarrhea. The patient has a history of drug abuse and possible Hepatitis C. HL is currently taking the following prescription drugs:
Synthroid 100 mcg daily
Nifedipine 30 mg daily
Prednisone 10 mg daily
Think about a possible diagnosis for the patient. Consider whether the patient has a disorder related to the gastrointestinal and hepatobiliary system or whether the symptoms are the result of a disorder from another system or other factors such as pregnancy, drugs, or a psychological disorder.
Consider an appropriate drug therapy plan based on the patiArcangelo, V. P., & Peterson, A. M. (Eds.). (2013). Pharmacotherapeutics for advanced practice: A practical approach (3rd ed.). Ambler, PA: Lippincott Williams & Wilkins. ent’s history, diagnosis, and drugs currently prescribed.
Starr, S., & Raines, D. (2011). Cirrhosis: Diagnosis, management, and prevention. American Family Physician, 84(12), 1353–1359.
Retrieved from the Walden Library databases.
Pharmacotherapy For Gastrointestinal and Hepatobiliary Disorders Name Course Instructor Date Hepatitis C is one of the leading causes of cirrhosis and increases the risk of health complications especially when there is liver inflammation (Starr, & Raines, 2011). Before intervening, there is a need to understand the patient’s medical history since the medication may influence measures undertaken to improve the patient’s well be